Golden Throat Holdings Group Company Limited (6896.HK)
HKD 3.08
(-0.65%)
HKD 3.08
(-0.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 961.37 Million CNY | -3.09% |
| 2022 | 992.01 Million CNY | 20.9% |
| 2021 | 820.54 Million CNY | 26.83% |
| 2020 | 646.94 Million CNY | -18.84% |
| 2019 | 797.12 Million CNY | 14.83% |
| 2018 | 694.19 Million CNY | 11.23% |
| 2017 | 624.08 Million CNY | -18.76% |
| 2016 | 768.17 Million CNY | 8.66% |
| 2015 | 706.92 Million CNY | 16.5% |
| 2014 | 606.8 Million CNY | 10.56% |
| 2013 | 548.85 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q4 | 481.73 Million CNY | 0.43% |
| 2023 FY | 961.37 Million CNY | -3.09% |
| 2023 Q2 | 479.64 Million CNY | -29.45% |
| 2022 Q4 | 679.9 Million CNY | 117.84% |
| 2022 FY | 992.01 Million CNY | 20.9% |
| 2022 Q2 | 312.11 Million CNY | -30.22% |
| 2021 Q4 | 447.25 Million CNY | 19.81% |
| 2021 Q2 | 373.29 Million CNY | -15.74% |
| 2021 FY | 820.54 Million CNY | 26.83% |
| 2020 Q2 | 203.92 Million CNY | -53.92% |
| 2020 FY | 646.94 Million CNY | -18.84% |
| 2020 Q4 | 443.02 Million CNY | 117.25% |
| 2019 FY | 797.12 Million CNY | 14.83% |
| 2019 Q4 | 442.5 Million CNY | 24.78% |
| 2019 Q2 | 354.62 Million CNY | -12.4% |
| 2018 Q4 | 404.8 Million CNY | 39.88% |
| 2018 FY | 694.19 Million CNY | 11.23% |
| 2018 Q2 | 289.39 Million CNY | -25.52% |
| 2017 Q4 | 388.53 Million CNY | 64.94% |
| 2017 FY | 624.08 Million CNY | -18.76% |
| 2017 Q2 | 235.55 Million CNY | -40.75% |
| 2016 Q4 | 397.53 Million CNY | 7.26% |
| 2016 Q2 | 370.63 Million CNY | 3.4% |
| 2016 FY | 768.17 Million CNY | 8.66% |
| 2015 Q4 | 358.46 Million CNY | 2.87% |
| 2015 Q2 | 348.46 Million CNY | 9.34% |
| 2015 FY | 706.92 Million CNY | 16.5% |
| 2014 Q2 | 288.11 Million CNY | 89.92% |
| 2014 Q4 | 318.68 Million CNY | 10.61% |
| 2014 FY | 606.8 Million CNY | 10.56% |
| 2013 Q4 | 151.7 Million CNY | 0.0% |
| 2013 FY | 548.85 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 259.15 Million HKD | -270.962% |
| Grand Pharmaceutical Group Limited | 10.52 Billion HKD | 90.87% |
| Extrawell Pharmaceutical Holdings Limited | 59.09 Million HKD | -1526.75% |
| Wai Yuen Tong Medicine Holdings Limited | 783.88 Million HKD | -22.643% |
| Qianhai Health Holdings Limited | 961.29 Million HKD | -0.009% |
| Lee's Pharmaceutical Holdings Limited | 1.05 Billion HKD | 8.704% |
| Essex Bio-Technology Limited | 1.7 Billion HKD | 43.666% |
| Tongfang Kontafarma Holdings Limited | 809.1 Million HKD | -18.82% |
| PuraPharm Corporation Limited | 406.85 Million HKD | -136.292% |
| SSY Group Limited | 6.46 Billion HKD | 85.125% |
| JBM (Healthcare) Limited | 648.41 Million HKD | -48.266% |
| Jacobson Pharma Corporation Limited | 1.46 Billion HKD | 34.502% |
| China Resources Pharmaceutical Group Limited | 270.39 Billion HKD | 99.644% |